Sulzer (SUN) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
13 Jun, 2025Executive summary
Order intake rose 9.2% year-over-year to CHF 2,934.4 million in the first nine months of 2024, with all divisions contributing to growth.
Sulzer confirms increased full-year guidance, reflecting robust performance across divisions.
Financial highlights
Order backlog reached CHF 2.4 billion as of the reporting period.
Currency translation negatively impacted order intake by CHF 131.0 million due to Swiss Franc strength.
Excluding currency effects, order intake would have been CHF 3,065.4 million.
Outlook and guidance
Full-year 2024 guidance reaffirmed: order intake expected to increase 9–12%, sales to rise 9–11%.
Operational profitability anticipated at approximately 12% of sales.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sulzer
- Record sales, profit, and margins support a higher dividend and positive 2026 outlook.SUN
Q4 202526 Feb 2026 - Order and sales growth drove higher profitability and upgraded 2024 guidance.SUN
H1 20242 Feb 2026 - Targets above-market growth, >17% EBITDA margin, and >22% ROCE by 2028, fully self-financed.SUN
CMD 20241 Feb 2026 - Double-digit sales and order growth, higher margins, and strong 2025 outlook driven by backlog.SUN
H2 202416 Dec 2025 - Order intake recovers, Services grow double digits, Chemtech hit by delays; guidance reaffirmed.SUN
Q3 2025 TU2 Nov 2025 - Sales, EBITDA, and net income up; Chemtech lagged, outlook and dividend increased.SUN
H1 202524 Jul 2025 - Stable Q1 order intake and confirmed guidance, with strong Flow and Services growth.SUN
Q1 2025 TU23 Jun 2025